Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions

P Wattanachai, W Amornpinyo, P Konyoung… - Frontiers in …, 2023 - frontiersin.org
Introduction: Beta-lactam antibiotics are one of the most common causes of antibiotics-
related severe cutaneous adverse reactions (SCARs) including Stevens–Johnson syndrome …

HLA‐A*02:07 Allele Associates with Clarithromycin‐Induced Cutaneous Adverse Drug Reactions in Chinese Patients

SA Chen, LR Zhang, FP Yang, LL Yang… - Basic & Clinical …, 2018 - Wiley Online Library
Genetic risk factors could cause cutaneous adverse drug reactions (cADR s) in patients after
treatment with clarithromycin. This study explored the association of HLA class I genes with …

HLA-B* 51: 01 is strongly associated with clindamycin-related cutaneous adverse drug reactions

Y Yang, S Chen, F Yang, L Zhang, G Alterovitz… - The …, 2017 - nature.com
Clindamycin causes cutaneous adverse drug reactions (cADRs), sometimes with the
mechanisms of pathogenicity or risk factors unknown. This study aims to assess whether …

A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine

C Kloypan, N Koomdee, P Satapornpong, T Tempark… - Pharmaceuticals, 2021 - mdpi.com
Human leukocyte antigen (HLA) encoded by the HLA gene is an important modulator for
immune responses and drug hypersensitivity reactions as well. Genetic polymorphisms of …

Association of HLA-B* 15: 13 and HLA-B* 15: 02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population

CC Chang, CC Ng, CL Too, SE Choon… - The …, 2017 - nature.com
Phenytoin (PHT) is a common cause of severe cutaneous adverse reactions (SCARs),
including Stevens–Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and drug …

Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions

T Kongpan, S Mahasirimongkol… - Pharmacogenetics …, 2015 - journals.lww.com
Background Co-trimoxazole is a sulfonamide-containing antibiotic that is effective in the
treatment of several infections and for prophylaxis of Pneumocystis jiroveci pneumonia. This …

[HTML][HTML] Genetic markers of severe cutaneous adverse reactions

JW Jung, JY Kim, IW Park, BW Choi… - The Korean Journal of …, 2018 - ncbi.nlm.nih.gov
Adverse drug reactions can cause considerable discomfort. They can be life-threatening in
severe cases, requiring or prolonging hospitalization, impeding proper treatment, and …

[HTML][HTML] Epidemiology of severe cutaneous adverse drug reaction and its HLA association among pediatrics

H Esmaeilzadeh, S Farjadian, S Alyasin… - Iranian Journal of …, 2019 - ncbi.nlm.nih.gov
Severe cutaneous adverse drug reaction (SCAR) is considered to be a multifactorial drug
side effect. This study was designed to investigate the epidemiology and human leukocyte …

Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art

T Jantararoungtong, T Tempark… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction: Pharmacogenomics has great potential in reducing drug-induced severe
cutaneous adverse drug reactions (SCARs). Pharmacogenomic studies have revealed an …

HLA associations and clinical implications in T‐cell mediated drug hypersensitivity reactions: an updated review

CY Cheng, SC Su, CH Chen, WL Chen… - Journal of …, 2014 - Wiley Online Library
T‐cell mediated drug hypersensitivity reactions may range from mild rash to severe fatal
reactions. Among them, drug reaction with eosinophilia and systemic symptoms (DRESS) or …